NEIL D THEISE, M.D.
Medical Practice at Nathan D Perlman Pl, New York, NY
License number
New York 171759
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
2
10 Nathan D Perlman Pl SUITE 12S34, New York, NY 10003
1900 Hempstead Tpke SUITE 500, Hempstead, NY 11554
1900 Hempstead Tpke SUITE 500, Hempstead, NY 11554
Phone
(212) 420-2124
(212) 420-3449 (Fax)
(516) 542-1090
(770) 666-9097 (Fax)
(212) 420-3449 (Fax)
(516) 542-1090
(770) 666-9097 (Fax)
Personal information
See more information about NEIL D THEISE at radaris.comName
Address
Phone
324 2Nd Ave APT 1R, New York, NY 10003
413 Grand St APT F1405, New York, NY 10002
New York, NY
324 2Nd Ave #1R, New York, NY 10003
413 Grand St #1406, New York, NY 10002
Professional information
Attending Physician At Beth Israel Medical Center - Albert Einstein College Of Medicine
Position:
Attending Physician at Beth Israel medical Center - Albert Einstein College of Medicine, Attending at Beth Israel Medical Center
Location:
Greater New York City Area
Industry:
Medical Practice
Work:
Beth Israel medical Center - Albert Einstein College of Medicine
-
Attending Physician
Beth Israel Medical Center
since 2003
-
Attending
Dr. Neil D Theise, New York NY - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
10 Nathan D Perlman Pl, New York 10003
(212) 420-2124 (Phone), (212) 420-3449 (Fax)
(212) 420-2124 (Phone), (212) 420-3449 (Fax)
Certifications:
Anatomic Pathology, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1986
Ny and Presby Hp Columbia Campus
Columbia University / College of Physicians And Surgeons
Graduated: 1986
Ny and Presby Hp Columbia Campus
Neil Theise, New York NY - Teacher
Specialties:
Medicine
Work:
New York University School of Medicine - New York NY
Multi-Organ Engraftment With A Single Bone Marrow-Derived Stem Cell
US Patent:
2003009, May 22, 2003
Filed:
Jun 7, 2002
Appl. No.:
10/165533
Inventors:
Diane Krause - Hamden CT, US
Neil Theise - New York NY, US
Michael Collector - Baltimore MD, US
Saul Sharkis - Towson MD, US
Neil Theise - New York NY, US
Michael Collector - Baltimore MD, US
Saul Sharkis - Towson MD, US
International Classification:
A61K045/00, C12N005/08
US Classification:
424/093700, 435/372000
Abstract:
Purification of rare Hematopoietic Stem Cells (HSC) to homogeneity is required to study their self-renewal, differentiation, phenotype, survival, and homing. Long-term repopulation (LTR) of irradiated hosts and serial transplantation to secondary hosts are the gold standard for demonstrating self renewal and differentiation, the defining properties of HSC's. We show that selection of rare cells that home rapidly to the bone marrow enriches for individual cells that can LTR primary and secondary recipients. During the procedure, CD34 and SCA-1 expression increases uniquely on cells that home to marrow. These adult bone marrow cells have nearly embryonic differentiation potential as they can also differentiate into epithelial cells of the liver, lung, GI tract, and skin. This finding is of great scientific importance and can be applied to clinical treatment of genetic disease or tissue repair.
System And Method For Diagnosis And Treatment
US Patent:
2012020, Aug 9, 2012
Filed:
Feb 2, 2012
Appl. No.:
13/364651
Inventors:
Randice Lisa Altschul - Cliffside Park NJ, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Assignee:
POP TEST CORTISOL LLC - Cliffside Park NJ
International Classification:
A61K 31/58, A61K 51/00, A61K 31/7068, A61K 33/24, A61K 31/665, A61K 31/7076, A61K 38/12, A61K 31/704, A61K 38/50, A61P 25/24, A61P 25/18, A61P 5/00, A61P 35/02, C07J 17/00, G01N 33/566, G01N 33/53, C40B 30/04, A61N 5/00, A61J 1/05, A61P 35/00, B82Y 5/00
US Classification:
424 111, 514174, 514171, 514 49, 424649, 514110, 514 48, 514 192, 514 34, 514170, 424 946, 540116, 436501, 435 79, 506 9, 422430, 600 1, 604403, 977773, 977915
Abstract:
This invention relates to a low cost rapid response diagnostic system to determine cortisol levels in patients selected as potential candidates for GCR (glucocorticoid receptor) antagonist therapy utilizing a GCR antagonist, such as ORG 34517. The rapid, sensitive, and inexpensive test can be used to determine patients who have non-normal cortisol production or disordered circadian rhythms as a method for selecting subjects for GCR antagonist therapy for whom it is likely to have beneficial and/or therapeutic effects, and can also be used to monitor changes in cortisol levels in response to treatment.
Therapeutic Compositions And Methods
US Patent:
2014003, Jan 30, 2014
Filed:
Mar 15, 2013
Appl. No.:
13/837408
Inventors:
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Assignee:
POP TEST CORTISOL LLC - Cliffside Park NJ
International Classification:
A61K 31/58, A61K 45/06, A61K 35/12, A61K 31/565
US Classification:
424 937, 514174, 514179, 514171
Abstract:
This invention relates the use of cortisol blockers (glucocorticoid receptor [GR] antagonists) for the prevention or addiction induced anxiety and withdrawal side effects as a therapeutic and in concert with a diagnostic. Such addictions could be, but are not limited to, alcohol, drugs, caffeine, sugar, food, nicotine, etc. The present invention further relates to the use of cortisol blockers (GR antagonists) for wound healing and transplants, the prevention or treatment of stress induced osteoporosis and the rapid healing of bone related injuries, and regenerative therapy.
Prevention Of Infection
US Patent:
2012025, Oct 4, 2012
Filed:
Mar 28, 2012
Appl. No.:
13/432174
Inventors:
Randice Lisa Altschul - Cliffside Park NJ, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Assignee:
POP TEST CORTISOL LLC - Cliffside Park NJ
International Classification:
A61J 1/14, A61P 31/00, A61J 1/00, A61K 31/56
US Classification:
604403, 514182, 206570
Abstract:
The invention relates to compounds and methods for the prevention and/or treatment of infection after stroke.
Diagnostic Device
US Patent:
2012028, Nov 8, 2012
Filed:
May 4, 2012
Appl. No.:
13/463956
Inventors:
Randice Lisa Altschul - Cliffside Park NJ, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Assignee:
POP TEST, LLC - Cliffside Park NJ
International Classification:
C12M 1/42, G01N 21/76, G01N 33/558
US Classification:
435 792, 4352872, 4352878, 436501, 422 69, 422 52
Abstract:
The invention provides for rapid response analysis through lateral flow chromatographic assays of specific antigens present in human or animal fluids, or in agricultural, microbial or biological products, with an audio and visual result of the analysis and when needed, an electronic surge to provide heat for rapid results. A lateral flow device for conducting the analysis includes a plurality of components, and a method for making the device forms components of the device on an elongate, ribbon-like substrate of dielectric material, then folds the substrate into shorter lengths which are then secured together to establish a multiple-layered, self-sustaining structure.
Combination Therapy
US Patent:
2012024, Sep 27, 2012
Filed:
Mar 21, 2012
Appl. No.:
13/425964
Inventors:
Randice Lisa Altschul - Cliffside Park NJ, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Assignee:
POP TEST CORTISOL LLC - Cliffside Park NJ
International Classification:
A61J 1/05, A61P 29/00, A61P 19/00, A61P 19/04, A61P 21/00, A61P 1/00, A61P 1/18, A61P 7/00, A61P 9/00, A61P 5/00, A61P 13/00, A61P 13/12, A61P 13/10, A61P 25/00, A61P 27/00, A61J 1/00, A61K 31/573
US Classification:
604403, 514171, 206438, 206570
Abstract:
This invention relates to compositions and methods for treating GC-responsive conditions and for reducing and preventing side-effects of GC treatment in patients.
Hair Loss Treatment
US Patent:
2012026, Oct 18, 2012
Filed:
Apr 16, 2012
Appl. No.:
13/447345
Inventors:
Randice Lisa Altschul - Cliffside Park NJ, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Neil David Theise - New York NY, US
Myron Rapkin - Indianapolis IN, US
Rebecca O'Brien - Shell Knob MO, US
Assignee:
POP TEST CORTISOL LLC - Cliffside Park NJ
International Classification:
A61K 31/58, A61Q 1/12, A61Q 19/04, A61Q 3/02, A61Q 9/02, A61Q 5/06, A61Q 5/02, A61Q 5/12, A61Q 19/10, A61Q 17/04, A61Q 5/04, A61Q 15/00, A61Q 19/00, A61K 8/67, A61K 8/66, A61K 8/92, A61P 31/00, A61P 17/10, A61Q 19/02, A61P 17/14, A61P 17/00, A61Q 5/10, A61Q 9/04, A61K 38/43, A61K 36/886, A61K 8/97, A61K 31/704, B65D 69/00, A61K 8/63
US Classification:
424 59, 514172, 424 69, 424 61, 424 65, 424 62, 514174, 8405, 424 941, 424 63, 424744, 514 33, 206570
Abstract:
This invention relates to the use of cortisol blockers (glucocorticoid receptor [GR] antagonists) for the prevention or treatment of stress induced hair loss.